Jiangzhong Pharmaceutical Co Ltd (600750) — Cash Flow-to-Debt Ratio
Jiangzhong Pharmaceutical Co Ltd (600750) has a Cash Flow-to-Debt Ratio of 0.00x as of December 2025, meaning its operating cash flow of CN¥-2.91 Million could theoretically repay 0% of its total liabilities (CN¥2.18 Billion) in one year. Explore Jiangzhong Pharmaceutical Co Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jiangzhong Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Jiangzhong Pharmaceutical Co Ltd across 28 annual periods. Also explore 600750 total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Jiangzhong Pharmaceutical Co Ltd (1998–2025)
Year-by-year debt coverage analysis for Jiangzhong Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see Jiangzhong Pharmaceutical Co Ltd stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.45x | CN¥970.87 Million | CN¥2.18 Billion | ▲ +15.5% |
| 2024 | 0.39x | CN¥786.25 Million | CN¥2.04 Billion | ▼ -33.9% |
| 2023 | 0.58x | CN¥1.04 Billion | CN¥1.77 Billion | ▲ +1.1% |
| 2022 | 0.58x | CN¥1.02 Billion | CN¥1.77 Billion | ▼ -10.8% |
| 2021 | 0.65x | CN¥917.04 Million | CN¥1.42 Billion | ▼ -42.1% |
| 2020 | 1.12x | CN¥752.50 Million | CN¥672.27 Million | ▲ +45.7% |
| 2019 | 0.77x | CN¥641.18 Million | CN¥834.84 Million | ▼ -11.0% |
| 2018 | 0.86x | CN¥486.25 Million | CN¥563.53 Million | ▲ +209.9% |
| 2017 | 0.28x | CN¥124.93 Million | CN¥448.74 Million | ▼ -82.1% |
| 2016 | 1.55x | CN¥698.05 Million | CN¥449.96 Million | ▼ -1.7% |
| 2015 | 1.58x | CN¥510.78 Million | CN¥323.74 Million | ▲ +427.9% |
| 2014 | 0.30x | CN¥356.80 Million | CN¥1.19 Billion | ▲ +129.4% |
| 2013 | 0.13x | CN¥111.92 Million | CN¥859.15 Million | ▼ -32.3% |
| 2012 | 0.19x | CN¥226.38 Million | CN¥1.18 Billion | ▼ -23.2% |
| 2011 | 0.25x | CN¥168.30 Million | CN¥671.11 Million | ▼ -18.0% |
| 2010 | 0.31x | CN¥222.29 Million | CN¥726.93 Million | ▼ -57.6% |
| 2009 | 0.72x | CN¥378.32 Million | CN¥524.73 Million | ▲ +65.4% |
| 2008 | 0.44x | CN¥268.87 Million | CN¥616.73 Million | ▲ +8.9% |
| 2007 | 0.40x | CN¥153.63 Million | CN¥383.89 Million | ▲ +312.9% |
| 2006 | 0.10x | CN¥55.24 Million | CN¥569.95 Million | ▼ -78.1% |
| 2005 | 0.44x | CN¥198.45 Million | CN¥449.20 Million | ▲ +743.4% |
| 2004 | 0.05x | CN¥26.28 Million | CN¥501.74 Million | ▼ -77.0% |
| 2003 | 0.23x | CN¥78.98 Million | CN¥347.14 Million | ▼ -60.3% |
| 2002 | 0.57x | CN¥94.90 Million | CN¥165.58 Million | ▲ +22.5% |
| 2001 | 0.47x | CN¥41.28 Million | CN¥88.23 Million | ▼ -37.5% |
| 2000 | 0.75x | CN¥121.77 Million | CN¥162.71 Million | ▲ +651.9% |
| 1999 | -0.14x | CN¥-21.89 Million | CN¥161.46 Million | ▼ -70.4% |
| 1998 | -0.08x | CN¥-11.42 Million | CN¥143.42 Million | — |